Doctor's Chief Medical Officer, John Whyte, MD, bespreekt het nieuwe door de FDA goedgekeurde preventieve geneesmiddel voor COVID-19, genaamd Evusheld.
Arts's Chief Medical Officer, Dr. John Whyte, spreekt met Dr. Valerie Rusch, President van het American College of Surgeons, over de terugkeer van electieve chirurgie.
Arts's Chief Medical Officer, John Whyte, spreekt met Todd Latz, CEO, GoHealth Urgent Care en Jeff David, mede-oprichter en Managing Director, Independent Pet Partners over de rol van de spoedeisende zorg tijdens de pandemie.
Arts's Chief Medical Officer, John Whyte, spreekt met Dr. Esther Choo, Spoedeisende Hulp arts en universitair hoofddocent aan de Oregon Health & Science University over wat zij meemaakt in de frontlinie van de COVID-19 pandemie.
Arts's Chief Medical Officer, John Whyte, spreekt met Laura E. Riley, MD, Immunization Expert Work Group Chair bij The American College of Obstetricians and Gynecologists (ACOG) over zwangerschap tijdens de COVID-19 pandemie.
Arts's Chief Medical Officer, John Whyte, spreekt met Luciana Borio, MD, Emergency Preparedness Expert en Vice President, In-Q-Tel over de voorbereiding op noodsituaties, wat er mis ging en of we voorbereid zijn op de toekomst?
Arts's Chief Medical Officer, John Whyte, spreekt met David C. Grabowski, PhD, Professor, Gezondheidszorgbeleid, Harvard Medical School en Terry Fulmer, PhD, RN, FAAN, President van The John A. Hartford Foundation over de Impact op Verpleeghuizen tijdens de COVID-19 pandemie.
Arts's Chief Medical Officer, John Whyte, spreekt met Jeffrey A. Lieberman, MD, Lawrence C. Kolb Professor en Voorzitter, Department of Psychiatry, Columbia University College of Physicians and Surgeons; Directeur, New York State Psychiatric Institute; en Psychiatrist-in-Chief, Columbia University Medical Center of the New York-Presbyterian Hospital. en Laurel S. Mayer, MD, Associate Professor of Clinical Psychiatry aan de Columbia University College of Physicians and Surgeons om te praten over COVID-19 en de geestelijke gezondheidsepidemie.
Arts's Chief Medical Officer, John Whyte, MD, bespreekt de laatste richtlijnen en aanbevelingen over het krijgen van uw tweede COVID-19 vaccin booster.
Arts's Chief Medical Officer, Dr. John Whyte, spreekt met J. Stephen Jones, MD, FACS. President en CEO, Inova Health System over hoe ziekenhuizen zich voorbereiden op de heropening.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duur
Beschrijving
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.